Agentic artificial intelligence (AI) gains popularity swiftly. This technology refers to AI systems designed to act autonomously towards specific goals. Agentic AI can plan, decide, take actions, and use tools without constant human prompting. Its goal-oriented behavior and decision-making capabilities make it valuable in different industries, involving healthcare. In this blog, we explore agentic AI in healthcare by focusing on real-world use cases. 

RFID ‌for Pharmaceuticals is a term used to describe the application of Radio Frequency Identification technology in monitoring, identifying, and handling pharmaceutical products at any given moment. RFID employs tags that are loaded with electronic data, readers, and software platforms for the automatic capturing and sharing of information without human intervention.In contrast to conventional barcode systems, RFID eliminates the need for line-of-sight scanning and can identify several items at once. Therefore, it is perfectly suitable for pharmaceutical settings where precision, quickness, and data validity are of prime ​‍​‌‍​‍‌importance.

En pratique, ces QR codes frauduleux se nichent un peu partout : e-mails, documents numériques ou supports imprimés. Ils poussent insidieusement leurs victimes à délaisser les environnements sécurisés de leur entreprise au profit de terminaux personnels, souvent bien moins protégés. Un simple scan conduit vers de fausses pages imitant habilement des plateformes cloud ou des accès VPN. Le but ? Dérober des identifiants, contourner l’authentification multifacteur (MFA), puis ouvrir la porte à d’autres intrusions.

Built on an innovative, patent-pending antenna architecture, LiquidMate O delivers reliable direct-on-vial RFID tagging for liquid-filled injectable medications, an application long considered one of the most technically challenging in RFID deployment. Ineffective tracking of injectable drugs continues to drive substantial losses through expired inventory, misplaced medications, and regulatory exposure—particularly for high-value or critical products. As enforcement of the U.S. Drug Supply Chain Security Act (DSCSA) accelerates, dependable, high-accuracy RFID-based medication tracking has become essential to both pharmaceutical manufacturing and hospital operations.

Let's be honest—QR codes are underutilized. We've built this remarkable global infrastructure for machine-readable symbols, with error correction baked right into the standard, and we use them almost exclusively as glorified hyperlinks. QPI v1 asked the provocative question: "What if the QR code wasn't a link, but the data itself?" This paper takes that question and runs with it, addressing every practical limitation head-on.

Des équipements de production aux solutions de conditionnement et d’étiquetage, des systèmes d’administration de médicaments aux services CDMO, chaque zone d’excellence proposée par le salon Pharmapack illustre une même réalité : la chaîne de valeur pharmaceutique n’est plus fragmentée, mais interconnectée, collaborative et orientée vers la performance globale. L’innovation ne se limite plus à la molécule. Elle s’exprime désormais à chaque étape du cycle de vie.

Electronic consent systems hold significant promise for improving the informed consent process, particularly in rare disease research. By making the process more accessible, transparent, and user-friendly, eConsent platforms can enhance participant understanding, encourage data sharing, and streamline administrative tasks. The recommendations discussed, i.e. enhancing usability, improving communication, and strengthening data accuracy, are essential steps in ensuring that the consent process is ethical, robust and effective.

The maker of Ritz is recalling four carton sizes of cracker sandwiches after mislabeled packaging could pose a threat to people with nut allergies.

A popular ice cream brand has recalled one of its flavors due to a packaging error. DFA Dairy Brands, LLC issued a recall on 324 cartons of Friendly’s 48 fluid-ounce Cookies & Cream ice cream, according to a report shared Wednesday by the United States Food and Drug Administration (FDA). The recall was issued after it was discovered that the product was packaged in the Vanilla Bean flavor carton with a Cookies & Cream lid.

Counterfeit and substandard pharmaceuticals threaten the health of millions around the world. The World Health Organization (WHO) defines them as products that do not meet quality standards and specifications due to poor manufacturing or inadequate quality control. According to the agency, at least 1 in 10 medicines in low- and middle-income countries are substandard or falsified. As the WHO emphasizes the negative impact of counterfeit and substandard drugs on public health, relevant stakeholders must build clean and transparent pharmaceutical supply chains.  

RFID in Pharmaceuticals Market is anticipated to expand from $3.2 billion in 2024 to $9.8 billion by 2034, growing at a CAGR of approximately 11.8%. This rapid growth reflects the increasing adoption of Radio Frequency Identification (RFID) technology to enhance tracking, authentication, and management of pharmaceutical products.

From sourcing active pharmaceutical ingredients (APIs) and managing strict cold-chain protocols to navigating evolving regulatory landscapes, the sector faces mounting pressure from internal inefficiencies and external disruptions. Recent years have amplified these challenges, exposing vulnerabilities that threaten both operational continuity and patient outcomes.

New study identifies the pharmaceutical firms with the most drug recalls in the U.S. from 2012-2024. Aidapak Services leads with 538 total recalls, while King Bio Inc. tops the list for most hazardous Class I recalls with 465 dangerous violations. The data reveals significant fluctuations in pharmaceutical recall activity over the past 13 years. 2019 stands out as the worst year on record.

As the threat of counterfeiting continues to torment industry stakeholders and patients, more strategic approaches to serialization and traceability are forming.

In today’s fast-paced world, industries like pharma, food, and manufacturing face increasing pressure to maintain transparency, ensure compliance, and deliver products safely to customers. This is where a Track and Trace System comes in. From monitoring product journeys with barcode scanners to real-time insights through a GPS tracking system, businesses are adopting these solutions to improve efficiency, customer trust, and regulatory adherence. If you run a business in pharmaceutical packaging, food supply chains, or large-scale manufacturing, understanding the role of a track and trace system is no longer optional—it’s essential for growth and compliance.

At its essence, track and trace is a method of identifying, recording, and tracing the movement of a product at each point in the supply chain—from the sourcing of raw materials through manufacturing to distribution, retail, and ultimately, the end user.Imagine it like a virtual passport for every item. In contrast to legacy batch-level tracking, newer systems tend to take advantage of one-of-a-kind item-level serialization. This refers to the fact that each product—each pill bottle, each bottle of wine, each designer sweater—is assigned a unique, tamper-resistant identity.

The pharmaceutical industry is in a constant state of evolution, driven by technological advancements that are redefining everything from drug discovery to patient care. One of the most significant shifts is happening in a once-overlooked area: packaging. Far from being just a container, pharmaceutical packaging is now a critical component of the digital health ecosystem, offering unprecedented levels of safety, data, and efficiency.Smart packaging is at the forefront of this transformation. By integrating digital technologies into traditional packaging formats, companies are unlocking new capabilities that enhance product integrity, improve supply chain visibility, and strengthen regulatory compliance. This article explores the current innovations in smart packaging and examines the operational and strategic benefits for pharmaceutical companies.

Sustainability in retail is no longer a moral side-note it’s becoming a core expectation. From packaging and supply chains to customer communication, brands are under pressure to eliminate waste, increase transparency and create more responsible experiences. Yet many of the solutions that promise sustainability often demand expensive tools, new systems or major operational changes.

Otsuka ICU Medical LLC is issuing a voluntary recall to the user level, for a MISLABELLED lot of POTASSIUM CHLORIDE Inj. 20 mEq, NDC 0990-7077-14. The OVERWRAP label of lot 1030613, Expiration Date: 09-30-2026 may incorrectly identify the product as POTASSIUM CHLORIDE Inj. 10 mEq with NDC 0990-7074-26. Otsuka ICU Medical LLC has identified this discrepancy due to a manufacturing issue. The dosage is correctly printed on the labeling affixed to the product bag which is not visible when the 10 mEq OVERWRAP is in place. This notification details the issue and the required steps for you to perform.

In today’s fast-moving business world, transparency has become the foundation of trust between brands, retailers, and customers. Whether it’s food, pharma, or FMCG, people want to know where their products come from and how they reach them. That’s where QR track and trace comes into play, a technology that brings unmatched clarity, accountability, and efficiency across supply chains.